Form 8-K - Current report:
SEC Accession No. 0001279569-21-001179
Filing Date
2021-08-18
Accepted
2021-08-17 21:33:29
Documents
14
Period of Report
2021-08-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K fourfront8k.htm   iXBRL 8-K 28813
2 NEWS RELEASE DATED AUGUST 16, 2021 ex991.htm EX-99.1 113877
3 GRAPHIC logo.jpg GRAPHIC 2466
  Complete submission text file 0001279569-21-001179.txt   333296

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA na-20210816.xsd EX-101.SCH 3094
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE na-20210816_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE na-20210816_pre.xml EX-101.PRE 22368
7 EXTRACTED XBRL INSTANCE DOCUMENT fourfront8k_htm.xml XML 3543
Mailing Address 2900-550 BURRARD STREET VANCOUVER A1 V6C 0A3
Business Address 2900-550 BURRARD STREET VANCOUVER A1 V6C 0A3 (602) 682-7037
4Front Ventures Corp. (Filer) CIK: 0001783875 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56075 | Film No.: 211184869
SIC: 2833 Medicinal Chemicals & Botanical Products